Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Total Liabilities & History | Stock Alarm

Lineage Cell Therapeutics, Inc. Common Stock · Total Liabilities

LCTX Total Liabilities

Latest reported$69.24Mperiod endingDec 31, 2025

LCTX FY Total Liabilities ($200.00K → $69.24M)

Annual total liabilities

High-resolution chart · PNG

LCTX total liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Liabilities — Annual fiscal periods (USD)
Period ending	Total Liabilities (USD)
Dec 31, 2025	69,238,000
Dec 31, 2024	36,206,000
Dec 31, 2023	38,996,000
Dec 31, 2022	51,728,000
Dec 31, 2021	83,647,000
Dec 31, 2020	12,822,000
Dec 31, 2019	14,231,000
Dec 31, 2018	9,414,000
Dec 31, 2017	8,978,000
Dec 31, 2016	12,064,000
Dec 31, 2015	18,213,000
Dec 31, 2014	12,178,141
Dec 31, 2013	15,467,429
Dec 31, 2012	5,454,220
Dec 31, 2011	4,371,514
Dec 31, 2010	3,847,002
Dec 31, 2009	2,386,082
Dec 31, 2008	5,382,271
Dec 31, 2007	3,221,491
Dec 31, 2006	2,515,728
Dec 31, 2005	2,155,365
Dec 31, 2004	1,176,819
Dec 31, 2003	3,502,096
Dec 31, 2002	2,667,227
Dec 31, 2001	2,040,469
Dec 31, 2000	359,749
Dec 31, 1999	595,512
Dec 31, 1998	400,000
Jun 30, 1998	1,000,000
Jun 30, 1996	200,000
Jun 30, 1995	400,000
Jun 30, 1994	100,000
Jun 30, 1993	100,000
Jun 30, 1992	200,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.